Dimethyl Fumarate as the Peripheral Blood Inflammatory Mediators Inhibitor in Prevention of Streptozotocin-Induced Neuroinflammation in Aged Rats

References

• Franceschi C, Capri M, Monti D, et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007;28:92–105. doi:10.1016/j.mad.2006.11.016
   Web of Science ®Google Scholar
• Pizza V, Agresta A, D’Acunto CW, Festa M, Capasso A. Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS Neurol Disord Drug Targets. 2011;10(5):621–634. doi:10.2174/187152711796235014
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006;12:1005–1015. doi:10.1038/nm1484
   PubMed Web of Science ®Google Scholar
• Stefanova NA, Ershov NI, Maksimowa KY, Muraleva NA, Tyumentsev MA, Kolosova NG. The rat prefrontal-cortex transcriptome: effects of aging and sporadic Alzheimer’s disease-like pathology. J Gerontol A Biol Sci Med Sci. 2019;74(1):33–43. doi:10.1093/gerona/gly198
   PubMed Web of Science ®Google Scholar
• Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA. Neuroinflammation – an early event in both the history and pathogenesis of Alzheimer’s disease. Neurodegener Dis. 2010;7(1–3):38–41. doi:10.1159/000283480
   PubMed Web of Science ®Google Scholar
• Heneka MT, Carson MJ, Khoury EJ, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14:388–405. doi:10.1016/S1474-4422(15)70016-5
   PubMed Web of Science ®Google Scholar
• Lehnardt S, Massilon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003;100(14):8514–8519. doi:10.1073/pnas.1432609100
   PubMed Web of Science ®Google Scholar
• Walker DG, Dalsing-Hemandez JE, Campbell NA, Lue LF. Decreased expression of CD 200 and CD 200 receptor in Alzheimer’s disease: a potential mechanism leading to chronic inflammation. Exp Neurol. 2009;215(1):5–19. doi:10.1016/j.expneurol.2008.09.003
   PubMed Web of Science ®Google Scholar
• Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet. 2011;43(5):436–441. doi:10.1038/ng.801
   PubMed Web of Science ®Google Scholar
• Neilson LE, Quinn JF, Gray NE. Peripheral blood NRF2 expression as a biomarker in human health and disease. Antioxidants. 2021;10(1):28. doi:10.3390/antiox10010028
   Web of Science ®Google Scholar
• Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136(1):28–42. doi:10.1093/brain/aws322
   PubMed Web of Science ®Google Scholar
• Nazem A, Sankowski R, Bacher M, Al-Abed Y. Rodent models of neuroinflammation for Alzheimer’s disease. J Neuroinflammation. 2015;17(12):74. doi:10.1186/s12974-015-0291-y
   Web of Science ®Google Scholar
• Chen Y, Liang Z, Blanchard J, et al. A nontransgenic mouse (icv-STZ mouse) of Alzheimer’s disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol Neurobiol. 2013;47:711–725. doi:10.1007/s12035-012-8375-5
   PubMed Web of Science ®Google Scholar
• Ferretti MT, Cuello AC. Does a pro-inflammatory process precede Alzheimer’s disease and mild cognitive impairment? Curr Alzheimer Res. 2011;8(2):164–174. doi:10.2174/156720511795255982
   PubMed Web of Science ®Google Scholar
• Kraska A, Santin MD, Dorieux O, et al. In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin. PLoS One. 2012;7(9):e46196. doi:10.1371/journal.pone.0046196
   PubMed Web of Science ®Google Scholar
• Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2013;9(1):25–34. doi:10.1038/nrneurol.2012.236
   PubMed Web of Science ®Google Scholar
• Salkovic-Petrisic M, Osmanovic-Barilar J, Brückner M, Hoyer S, Arendt T, Riederer P. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study. J Neural Transm. 2011;118(5):765–772. doi:10.1007/s00702-011-0651-4
   PubMed Web of Science ®Google Scholar
• Mishra SK, Singh S, Shukla S, Shukla R. Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats. Neurochem Int. 2018;113:56–68. doi:10.1016/j.neuint.2017.11.012
   PubMed Web of Science ®Google Scholar
• Kamat P, Kalani A, Rai S, et al. Streptozotocin intracerebroventricular induced neurotoxicity and brain insulin resistance therapeutic intervention for treatment of Sporadic Alzheimer’s Disease (sAD)-like pathology. Mol Neurobiol. 2016;53(7):4548–4562. doi:10.1007/s12035-015-9384-y
   PubMed Web of Science ®Google Scholar
• Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity, uncovering the molecular mechanicms. Nat Rev Neurosci. 2007;8(1):57–69. doi:10.1038/nrn2038
   PubMed Web of Science ®Google Scholar
• Salminen A. Activation of immunosuppression network in the aging process. Ageing Res Rev. 2020;57:100998. doi:10.1016/j.arr.2019.100998
   PubMed Web of Science ®Google Scholar
• Jones CI. Platelet function and ageing. Mamm Genome. 2016;27(7–8):358–366. doi:10.1007/s00335-016-9629-8
   PubMed Web of Science ®Google Scholar
• Kniewallner KM, Foidl BM, Humpel C. Platelets isolated from an Alzheimer’s mouse damage healthy cortical vessels and cause inflammation in an organotypic ex vivo brain slice model. Sci Rep. 2018;8(1):15483. doi:10.1038/s41598-018-33768-2
   PubMed Web of Science ®Google Scholar
• Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ. Platelets, lymphocytes and erythrocytes from Alzheimer’s disease patients: the quest for blood cell-based biomarkers. Folia Neuropathol. 2018;56(1):14–20. doi:10.5114/fn.2018.74655
   PubMed Web of Science ®Google Scholar
• Canobbio I, Abubaker AA, Viscante C, Torti M, Paula G. Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease. Front Cell Neurosci. 2015;9:65. doi:10.3389/fncel.2015.00065
   PubMed Web of Science ®Google Scholar
• Stevenson A, Lopez D, Khoo P, Kalaria RN, Mukaetova-Ladinska EB. Exploring erythrocytes as blood biomarkers for Alzheimer’s disease. J Alzheimers Dis. 2017;60:845–857. doi:10.3233/JAD-170363
   PubMed Web of Science ®Google Scholar
• Gonzalez H, Pacheco R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation. 2014;11(1):201. doi:10.1186/s12974-014-0201-8
   PubMed Web of Science ®Google Scholar
• Mietelska-Porowska A, Wojda U. T lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer’s disease: potential pools of new biomarkers. J Immunol Res. 2017;2017:4626540. doi:10.1155/2017/4626540
   PubMed Web of Science ®Google Scholar
• Richartz-Salzburger E, Batra A, Stransky E, et al. Altered lymphocyte distribution in Alzheimer’s disease. J Psychiatr Res. 2007;41(1–2):174–178. doi:10.1016/j.jpsychires.2006.01.010
   PubMed Web of Science ®Google Scholar
• Saidu NEB, Kavian N, Leroy K, Jakob C, Nicco C, Batteux F. Dimethyl fumarate, a two-edged drug: current status and future directions. Med Res Rev. 2019;39(5):1923–1952. doi:10.1002/med.21567
   PubMed Web of Science ®Google Scholar
• Diebold M, Sievers C, Bantug G, et al. T Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis. J Autoimmun. 2018;86:39–50. doi:10.1016/j.jaut.2017.09.009
   PubMed Web of Science ®Google Scholar
• Carlström KE, Ewing E, Granquist M, et al. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes. Nature Commun. 2019;10:3081. doi:10.1038/s41467-019-11139-3
   PubMed Web of Science ®Google Scholar
• Tahvili S, Zandich B, Amirghofran Z. The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis. Int J Dermatol. 2015;54(7):e254–e260. doi:10.1111/ijd.12834
   PubMed Web of Science ®Google Scholar
• Majkutewicz I, Kurowska E, Podlacha M, et al. Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats. Behav Brain Res. 2016;308:24–37. doi:10.1016/j.bbr.2016.04.012
   PubMed Web of Science ®Google Scholar
• Majkutewicz I, Kurowska E, Podlacha M, et al. Age-dependent effects of dimethyl fumarate on cognitive and neuropathological features in the streptozotocin-induced rat model of Alzheimer’s disease. Brain Res. 2018;1686:19–33. doi:10.1016/j.brainres.2018.02.016
   PubMed Web of Science ®Google Scholar
• Spencer SR, Wilczak CA, Talalay P. Induction of glutathione transferases and NAD(P)H: quinonereductase by fumaric acid derivatives in rodent cells and tissues. Cancer Res. 1990;50(24):7871–7875.
   PubMed Web of Science ®Google Scholar
• Sasaki A, Koike N, Murakami T, Suzuki K. Dimethyl fumarate ameliorates cisplatin-induced renal tubulointerstitial lesions. J Toxicol Pathol. 2019;39:79–89. doi:10.1293/tox.2018-0049
   Web of Science ®Google Scholar
• Dhaliwal N, Dhaliwal J, Singh A, Chopra K. Dimethyl fumarate attenuates 2-VO-induced vascular dementia via activating the Nrf-2 signaling pathway in rats. Inflammopharmacology. 2021;29:537–547. doi:10.1007/s10787-020-00785-5
   PubMed Web of Science ®Google Scholar
• Bloch K, Gil-Ad I, Vanichkin A, et al. Intracerebroventricular streptozotocin induces obesity and dementia in Luis rats. J Alzheimers Dis. 2017;60:121–136. doi:10.3233/JAD-161289
   PubMed Web of Science ®Google Scholar
• Wrona D, Listowska M, Kubera M, et al. Effects of chronic desipramine pretreatment on open field-induced suppression of blood natural killer cell activity and cytokine response depend on the rat’s behavioral characteristics. J Neuroimmunol. 2014;268:13–24. doi:10.1016/j.jneuroim.2013.10.001
   PubMed Web of Science ®Google Scholar
• Listowska M, Glac W, Grembecka B, Grzybowska M, Wrona D. Change in blood CD4+T and CD8+T lymphocytes in stressed rats pretreated chronically with desipramine are more pronounced after chronic open field stress challenge. J Neuroimmunol. 2015;282:54–62. doi:10.1016/j.jneuroim.2015.02.015
   PubMed Web of Science ®Google Scholar
• Glac W, Dunacka J, Grembecka B, Światek G, Majkutewicz I, Wrona D. Prolonged peripheral immunosuppressive responses as consequence of random amphetamine treatment, amphetamine withdrawal and subsequent amphetamine challenges in rats. J Neuroimmune Pharmacol. 2021. doi:10.1007/s11481-021-09988-1
   Web of Science ®Google Scholar
• Grembecka B, Glac W, Listowska M, et al. Subthalamic deep brain stimulation affects plasma corticosterone concentration and peripheral immunity changes in rat model of Parkinson’s disease. J Neuroimmune Pharmacol. 2021;16(2):454–469. doi:10.1007/s11481-020-09934-7
   PubMed Web of Science ®Google Scholar
• Ulrich-LAI YM, Herman JP. Neural regulation of endocrine and autonomic stress response. Nat Rev Neurosci. 2009;10:397–409. doi:10.1038/nrn2647
   PubMed Web of Science ®Google Scholar
• Montes D, Fraussen J, Wijmeersch B, Hupperts R, Somers V. Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients. Sci Rep. 2018;8:8194. doi:10.1038/s41598-018-26519-w
   PubMed Web of Science ®Google Scholar
• Longbrake EE, Cantoni C, Chahin S, Cignarella F, Cross AH, Piccio L. Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count. Mult Scler. 2018;24(6):728–738. doi:10.1177/1352458517707069
   PubMed Web of Science ®Google Scholar
• Vego H, Sand KL, Hoglund RA, et al. Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a. Cell Mol Immunol. 2016;13(1):57–64. doi:10.1038/cmi.2014.114
   PubMed Web of Science ®Google Scholar
• Smith MD, Calabresi P, Bhargava P. Dimethyl fumarate treatment alters NK cell function in multiple sclerosis. Eur J Immunol. 2018;48(2):380–383. doi:10.1002/eji.201747277
   PubMed Web of Science ®Google Scholar
• Crome SQ, Lang PA, Lang KS, Ohashi PS. Natural killer cells regulate diverse T cell responses. Trends Immunol. 2013;34(7):342–349. doi:10.1016/j.it.2013.03.002
   PubMed Web of Science ®Google Scholar
• Linker RA, Lee DH, Ryan S, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 2011;134(3):678–692. doi:10.1093/brain/awq386
   PubMed Web of Science ®Google Scholar
• Safdar A, deBeer J, Tarnopolsky MA. Dysfunctional Nrf-2-Keap1 redox signaling in skeletal muscle of the sedentary old. Free Radic Biol Med. 2010;49:1487–1493. doi:10.1016/j.freeradbiomed.2010.08.010
   PubMed Web of Science ®Google Scholar
• Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases, physiology and pathology. Physiol Rev. 2007;87:245–313. doi:10.1152/physrev.00044.2005
   PubMed Web of Science ®Google Scholar
• Ghadiri M, Rezk A, Li R, et al. Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis. Neurol Neuroimmunol Neuroinflamm. 2017;4:e340. doi:10.1212/NXI.0000000000000340
   PubMed Web of Science ®Google Scholar
• Sainz de la Maza S, Medina S, Villarrubia N, et al. Factors associated with dimethyl fumarate-induced lymphopenia. J Neurol Sci. 2019;398(4):4–8. doi:10.1016/j.jns.2019.01.007
   PubMed Web of Science ®Google Scholar
• Spencer CM, Crabtree-Hartman EC, Lehman-Horn K, Cree BA, Zamvil SS. Reduction of CD8+ T lymphocyte in multiple sclerosis patients treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm. 2015;2(3):e76. doi:10.1212/NXI.0000000000000076
   PubMed Web of Science ®Google Scholar
• Berkovich R, Weiner IP. Effects of dimethyl fumarate (Teefidera) on lymphocyte subsets. Mult Scler Relat Disord. 2015;4(4):339–341. doi:10.1016/j.msard.2015.06.002
   PubMed Web of Science ®Google Scholar
• Chaves C, Ganguly R, Ceresia C, Camac A. Lymphocyte subtypes in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate. Mult Scler J Exp Transl Clin. 2017;3(2):2055217317702933. doi:10.1177/2055217317702933
   Google Scholar
• Longbrake EE, Ramsbottom MJ, Cantoni C, Ghezzi L, Cross AH, Piccio L. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients. Mult Scler. 2016;22(8):1061–1070. doi:10.1177/1352458515608961
   PubMed Web of Science ®Google Scholar
• Medina S, Villarrubia N, Sainz de la Maza S, et al. Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile. Mult Scler. 2018;24(10):1317–1327. doi:10.1177/1352458517717088
   PubMed Web of Science ®Google Scholar
• Najjar E, Staun-Ram E, Volkowich A, Miller A. Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS. J Neuroimmunol. 2020;343:577230. doi:10.1016/j.jneuroim.2020.577230
   PubMed Web of Science ®Google Scholar
• Albrecht P, Bouchachia I, Goebels N, et al. Effects of dimethyl fumarate on neuroprotection and immunomodulation. J Neuroinflammation. 2012;9(1):163. doi:10.1186/1742-2094-9-163
   PubMed Web of Science ®Google Scholar
• Borger P, Postma DS, Vellenga E, Kaufman HF. Regulation of asthma-related T-cell cytokines by the cyclic AMP-dependent signaling pathway. Clin Exp Allergy. 2000;30:920–926. doi:10.1046/j.1365-2222.2000.00794.x
   PubMed Web of Science ®Google Scholar
• Fiedler SE, Kerns AR, Tsang C, Tsang V, Bourdette D, Salinthone S. Dimethyl fumarate activates the prostaglandin EP2 receptor and stimulates cAMP signaling in human peripheral blood mononuclear cells. Biochem Biophys Res Commun. 2016;475:19–24. doi:10.1016/j.bbrc.2016.05.021
   PubMed Web of Science ®Google Scholar
• Zidek Z. Adenosine-cyclic AMP pathway and cytokine expression. Eur Cytokine Netw. 1999;10:319–328.
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Kiko T, Kuriwada S, Miyazawa T, Kimura F, Miyazawa T. Amyloid β induces adhesion of erythrocytes to endothelial cells and affects endothelial viability and functionality. Biosci Biotechnol Biochem. 2011;75(10):2030–2033. doi:10.1271/bbb.110318
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy S, Pace B, Gupta D, et al. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease. JCI Insight. 2017;2(20):e96409. doi:10.1172/jci.insight.96409
   PubMed Web of Science ®Google Scholar
• Macari ER, Lowrey CH. Induction of human fetal hemoglobin via NRF-2 antioxidant response signaling pathway. Blood. 2011;117(22):5987–5997. doi:10.1182/blood-2010-10-314096
   PubMed Web of Science ®Google Scholar
• Suidan GL, Singh PK, Patel-Hett S, et al. Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability. Blood Adv. 2018;2(9):954–963. doi:10.1182/bloodadvances.2018017798
   PubMed Web of Science ®Google Scholar
• Yadav SK, Soin D, Ito K, Dhib-Jalbut S. Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis. J Mol Med. 2019;97(4):463–472. doi:10.1007/s00109-019-01761-5
   PubMed Web of Science ®Google Scholar
• Kunze R, Urrutia A, Hoffmann A, et al. Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity. Exp Neurol. 2015;266:99–111. doi:10.1016/j.expneurol.2015.02.022
   PubMed Web of Science ®Google Scholar
• Lim JL, van der Pol SM, Di Dio F, et al. Protective effects of monomethyl fumarate at the inflamed blood-brain barrier. Microvasc Res. 2016;105:61–69. doi:10.1016/j.mvr.2015.12.003
   PubMed Web of Science ®Google Scholar